Ventripoint Diagnostics Ltd.

TSXV:VPT Stock Report

Market Cap: CA$16.2m

Ventripoint Diagnostics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

TSXV:VPT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Dec 24SellCA$3,215Victor HugoIndividual32,656CA$0.10
31 Oct 24SellCA$7,575Victor HugoIndividual50,500CA$0.15
18 Oct 24BuyCA$16,215Victor HugoIndividual83,156CA$0.20
02 May 24BuyCA$4,420Hugh MacNaughtIndividual20,000CA$0.22
26 Apr 24BuyCA$945Robert HodgkinsonIndividual4,500CA$0.21
25 Apr 24BuyCA$840Robert HodgkinsonIndividual4,000CA$0.21
25 Apr 24BuyCA$9,692Robert HodgkinsonIndividual45,500CA$0.21
24 Apr 24BuyCA$4,410Robert HodgkinsonIndividual21,000CA$0.21
23 Apr 24BuyCA$5,425Robert HodgkinsonIndividual25,000CA$0.22
22 Apr 24BuyCA$15,900Robert HodgkinsonIndividual75,000CA$0.21
22 Apr 24BuyCA$5,250Robert HodgkinsonIndividual25,000CA$0.21
18 Apr 24BuyCA$21,056Robert HodgkinsonIndividual100,000CA$0.21
12 Apr 24BuyCA$4,400Hugh MacNaughtIndividual20,000CA$0.22
28 Mar 24BuyCA$4,520Hugh MacNaughtIndividual20,000CA$0.23

Insider Trading Volume

Insider Buying: VPT insiders have bought and sold the same number of shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VPT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies100,0000.0617%
Individual Insiders704,0750.435%
General Public161,214,30199.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.3%.

Top Shareholders

Top 3 shareholders own 0.50% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.4%
George Adams
644,075CA$64.4k-31.6%no data
0.062%
Hemo Stat Ltd.
100,000CA$10.0k0%no data
0.037%
Hugh MacNaught
60,000CA$6.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 13:00
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ventripoint Diagnostics Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution